Fujian Shengdi Pharmaceutical Co., Ltd.

This early-stage study tested the safety and initial effectiveness of a new injection called HRS-7450 for people who recently had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The trial involved 64 participants who received the drug within 24 hours …

This early-stage study tested the safety and effects of a new injectable drug, HRS-9057, in people with heart failure who had too much fluid in their bodies despite taking water pills. It involved 25 participants who received either the new injection or a standard pill (tolvaptan…

This large, completed study tested whether a new drug called HR20013 works better than a standard drug (palonosetron) at preventing nausea and vomiting in cancer patients receiving chemotherapy that has a moderate risk of causing these side effects. It involved 706 adults who wer…

This was the first study in people to test a new drug called HRS-7249, which is being developed to treat high cholesterol. It involved 48 healthy volunteers with high triglycerides to check if a single injection was safe and how the body processed it. The main goal was to find a …